Hikal informs about disclosure

23 Feb 2024 Evaluate
Hikal has informed that the Hon’ble High Court of Bombay, vide its order dated February 22, 2024, has disposed of the writ petition, filed by the Company challenging the jurisdiction of the principal bench of NGT, as not maintainable and granted liberty to the Company to seek remedies as available under law. The order of Hon’ble Bombay High Court shall operate on the expiry of a period of 4 weeks from February 22, 2024. The Hon’ble High Court has further extended the interim relief granted to the Company under its order dated March 24, 2023 for a period of 4 weeks from February 22, 2024, to enable the Company to invoke appropriate remedy.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

242.40 -10.55 (-4.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×